1. Home
  2. ITRM vs INLX Comparison

ITRM vs INLX Comparison

Compare ITRM & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • INLX
  • Stock Information
  • Founded
  • ITRM 2015
  • INLX 1996
  • Country
  • ITRM Ireland
  • INLX United States
  • Employees
  • ITRM N/A
  • INLX 199
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • INLX EDP Services
  • Sector
  • ITRM Health Care
  • INLX Technology
  • Exchange
  • ITRM Nasdaq
  • INLX Nasdaq
  • Market Cap
  • ITRM 49.5M
  • INLX 59.0M
  • IPO Year
  • ITRM 2018
  • INLX N/A
  • Fundamental
  • Price
  • ITRM $1.75
  • INLX $13.70
  • Analyst Decision
  • ITRM Strong Buy
  • INLX
  • Analyst Count
  • ITRM 1
  • INLX 0
  • Target Price
  • ITRM $5.00
  • INLX N/A
  • AVG Volume (30 Days)
  • ITRM 1.6M
  • INLX 4.3K
  • Earning Date
  • ITRM 11-14-2024
  • INLX 11-13-2024
  • Dividend Yield
  • ITRM N/A
  • INLX N/A
  • EPS Growth
  • ITRM N/A
  • INLX N/A
  • EPS
  • ITRM N/A
  • INLX N/A
  • Revenue
  • ITRM N/A
  • INLX $17,930,991.00
  • Revenue This Year
  • ITRM N/A
  • INLX $9.27
  • Revenue Next Year
  • ITRM N/A
  • INLX $8.10
  • P/E Ratio
  • ITRM N/A
  • INLX N/A
  • Revenue Growth
  • ITRM N/A
  • INLX 7.17
  • 52 Week Low
  • ITRM $0.81
  • INLX $4.52
  • 52 Week High
  • ITRM $3.02
  • INLX $16.50
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 45.98
  • INLX 49.53
  • Support Level
  • ITRM $1.78
  • INLX $13.49
  • Resistance Level
  • ITRM $1.95
  • INLX $14.38
  • Average True Range (ATR)
  • ITRM 0.30
  • INLX 0.57
  • MACD
  • ITRM -0.10
  • INLX -0.07
  • Stochastic Oscillator
  • ITRM 0.00
  • INLX 47.96

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document strategy to convert documents from one medium to another.

Share on Social Networks: